| Abstrakt: |
A patent has been issued to Koninklijke Philips N.V. for methods of prostate cancer prognosis. Prostate cancer is a common malignancy in men, and current diagnostic methods often lead to unnecessary biopsies and complications. The patent describes a method that uses gene expression analysis to determine the presence and progression of prostate cancer, allowing for personalized treatment decisions and potentially avoiding unnecessary surgeries. The invention aims to improve diagnosis, prognosis, and treatment outcomes for prostate cancer patients while reducing costs and side effects. [Extracted from the article] |
